Siglimet is recommended as an adjunct to diet and exercise to enhance blood sugar control in adults with type 2 diabetes mellitus, especially when combination therapy with sitagliptin and metformin is appropriate.
Not suitable for patients with type 1 diabetes or diabetic ketoacidosis.
Safety has not been established in patients with a history of pancreatitis. It is unclear whether such patients are at higher risk of pancreatitis during treatment.
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
This combination tablet utilizes two complementary mechanisms to manage blood glucose:
Together, they offer a dual approach to improving glycemic control.
Gradual dose escalation is advised to minimize gastrointestinal side effects from metformin.
Maintain the same total daily dose when switching between immediate and extended-release forms.
May require dose adjustments to prevent hypoglycemia.
Do not use in patients with:
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.